Problem is that the benefits of license free medicine to society are diffuse, while the benefits of a licensing fee are concentrated. That makes lobbying and or

Problem is that the benefits of license free medicine to society are diffuse, while the benefits of a licensing fee are concentrated. That makes lobbying and organization/cooperation much easier for the entity that is developing the medicine. The public is not as likely to organize their interests and establish a competent lobbying strategy. Just not enough in it for a single person for them to pay attention.